International workgroup of geneticists issues CHEK2 guidelines
International workgroup issues additional guidance on how to manage patients who carry inherited CHEK2 gene mutations that put them at a higher risk for cancer.
A biomarker for early Type 2 diabetes
Levels of the essential, branched-chain amino acids, valine, leucine and isoleucine, are involved in the regulation of lipid, glucose and protein metabolism.
Record year for the Vanderbilt Transplant Center saves 739 lives
The Vanderbilt Transplant Center (VTC) established a new record in calendar year 2023 for total solid organ transplants, performing 739 lifesaving procedures among its adult and pediatric organ transplant programs.
Four physician-scientists from VUMC receive national early-career awards
Margaret Salisbury, MD, MS, a leader in the study and treatment of interstitial lung diseases at Vanderbilt University Medical Center, has received a Young Physician-Scientist Award from the Council of the American Society for Clinical Investigation (ASCI) for “notable achievements” in research.
Stokes Peebles appointed to the National Advisory Allergy and Infectious Diseases Council
Vanderbilt's Stokes Peebles, MD, has been appointed to the National Advisory Allergy and Infectious Diseases Council.
VUMC establishes Realizing Accelerated Progress, Investigation, Implementation, and Dissemination in Learning Health Systems (RAPID-LHS) Center
Vanderbilt University Medical Center has been awarded a $5 million grant from the Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute to establish a multidisciplinary center focused on training scientists and supporting research to minimize gaps between the generation of clinical evidence, implementation of proven interventions and development of informed public health policy.
Molecular profiles of tissue plus circulating tumor DNA can better guide cancer care
The current standard of care for identifying targetable mutations in cancer treatment is to conduct molecular profiles on tumor tissue samples, but a study published Monday in JAMA Network Open indicates that adding liquid biopsy testing for circulating tumor DNA mutations increases targetable mutation detection rates.
Hartmann named director of UK Center for Clinical and Translational Science
Katherine Hartmann, MD, PhD, Vice President for Research Integration for Vanderbilt University Medical Center, has been named director of the University of Kentucky (UK) Center for Clinical and Translational Science. She will also serve as associate vice president for Research, Clinical & Translational Science for UK, and she will be the associate dean of Research Development and Synergy and a professor of Obstetrics and Gynecology in the UK College of Medicine. She will join UK on Feb. 15.
Stanford, Essentia Health join VUMC-based clinical research network
The STAR Clinical Research Network, based at Vanderbilt University Medical Center (VUMC), has added two new partners — Essentia Health, a Minnesota-based rural health care system, and Stanford University School of Medicine, one of the country’s leading academic medical centers.